Table 2.

Multivariable predictors for the primary outcome

Characteristic	Hazard ratio (95% CI)	P-value
Statins	0.51 (0.46–0.57)	<0.0001
Age (per year)	1.03 (1.02–1.04)	<0.0001
Diabetes mellitus	1.39 (1.25–1.54)	<0.0001
Cerebrovascular disease	1.17 (1.06–1.30)	0.003
Peripheral arterial disease	1.12 (1.01–1.24)	0.03
Coronary artery disease	1.16 (1.04–1.30)	0.007
Heart failure	1.37 (1.21–1.55)	<0.0001
Aortic aneurysm (including surgery for)	0.85 (0.76–0.96)	0.009
Chronic kidney disease	1.22 (1.10–1.36)	0.0002
Chronic liver disease	1.30 (1.03–1.64)	0.03
Chronic lung disease	1.12 (1.01–1.24)	0.03
Peptic ulcer disease	0.83 (0.73–0.94)	0.003
Systemic malignancy	1.51 (1.26–1.81)	<0.0001
CADG3 (‘likely to recur’)	0.80 (0.68–0.95)	0.01
CADG7 (‘chronic specialty stable’)	0.82 (0.72–0.94)	0.004
Hospitalizations (n, past 3 years)	1.07 (1.05–1.10)	<0.0001
Drugs (n, past 6 months)	1.02 (1.01–1.03)	0.003
Calcium channel blockers	1.13 (1.02–1.25)	0.02
Loop diuretics	1.23 (1.09–1.40)	0.0008
Non-steroidal anti-inflammatory drugs	0.84 (0.73–0.98)	0.03

CADG, chronic ambulatory disease grouping.